tradingkey.logo
搜索

Heartflow Inc

HTFL
添加自选
28.315USD
-3.925-12.17%
收盘 05/15, 16:00美东报价延迟15分钟
2.44B总市值
亏损市盈率 TTM

Heartflow Inc

28.315
-3.925-12.17%

关于 Heartflow Inc 公司

HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.

Heartflow Inc简介

公司代码HTFL
公司名称Heartflow Inc
上市日期Aug 08, 2025
CEOFarquhar (John C. M)
员工数量699
证券类型Ordinary Share
年结日Aug 08
公司地址331 E Evelyn Avenue
城市MOUNTAIN VIEW
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编94041
电话16502411221
网址https://www.heartflow.com/
公司代码HTFL
上市日期Aug 08, 2025
CEOFarquhar (John C. M)

Heartflow Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
3.19M
+99.48%
Mr. Jeffrey C. Lightcap
Mr. Jeffrey C. Lightcap
Independent Director
Independent Director
246.26K
--
Mr. Vikram Verghese
Mr. Vikram Verghese
Chief Financial Officer
Chief Financial Officer
130.21K
-1.54%
Mr. Lonnie M. Smith
Mr. Lonnie M. Smith
Independent Director
Independent Director
34.25K
--
Dr. Charles A. Taylor, Ph.D.
Dr. Charles A. Taylor, Ph.D.
Director
Director
--
--
Dr. Campbell D. Rogers, M.D.
Dr. Campbell D. Rogers, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. John C. M. Farquhar
Mr. John C. M. Farquhar
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Julie Cullivan
Ms. Julie Cullivan
Independent Director
Independent Director
--
--
Mr. Tim Barabe
Mr. Tim Barabe
Independent Director
Independent Director
--
--
Dr. Wayne Riley, M.D.
Dr. Wayne Riley, M.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
3.19M
+99.48%
Mr. Jeffrey C. Lightcap
Mr. Jeffrey C. Lightcap
Independent Director
Independent Director
246.26K
--
Mr. Vikram Verghese
Mr. Vikram Verghese
Chief Financial Officer
Chief Financial Officer
130.21K
-1.54%
Mr. Lonnie M. Smith
Mr. Lonnie M. Smith
Independent Director
Independent Director
34.25K
--
Dr. Charles A. Taylor, Ph.D.
Dr. Charles A. Taylor, Ph.D.
Director
Director
--
--
Dr. Campbell D. Rogers, M.D.
Dr. Campbell D. Rogers, M.D.
Chief Medical Officer
Chief Medical Officer
--
--

收入明细

单位: USD更新时间: 4月6日 周一
单位: USD更新时间: 4月6日 周一
FY2025
FY2025Q4
FY2025Q3
FY2024
由于公司未披露,未能获取相关数据
地区USD
名称
营收
占比
United states
162.73M
92.44%
Rest of the world
13.30M
7.56%
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 5月14日 周四
更新时间: 5月14日 周四
持股股东
股东类型
持股股东
持股股东
占比
Wellington Management Company, LLP
13.82%
Bain Capital Life Sciences Investors, LLC
9.80%
Fidelity Management & Research Company LLC
4.66%
Tansey (Casey M)
3.70%
Baron Capital Management, Inc.
2.67%
其他
65.35%
持股股东
持股股东
占比
Wellington Management Company, LLP
13.82%
Bain Capital Life Sciences Investors, LLC
9.80%
Fidelity Management & Research Company LLC
4.66%
Tansey (Casey M)
3.70%
Baron Capital Management, Inc.
2.67%
其他
65.35%
股东类型
持股股东
占比
Investment Advisor
41.91%
Investment Advisor/Hedge Fund
23.87%
Individual Investor
5.19%
Hedge Fund
4.55%
Research Firm
0.31%
Bank and Trust
0.30%
Venture Capital
0.18%
Pension Fund
0.09%
Private Equity
0.04%
其他
23.55%

机构持股

更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q4
129
59.51M
43.48%
--
2026Q1
237
65.02M
75.47%
+2.36M
2025Q4
157
60.44M
71.29%
+22.15M
2025Q3
46
45.42M
54.46%
+42.91M

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Wellington Management Company, LLP
11.92M
13.9%
+6.03M
+102.26%
Feb 27, 2026
Bain Capital Life Sciences Investors, LLC
10.45M
12.18%
-2.00M
-16.07%
Feb 04, 2026
Fidelity Management & Research Company LLC
4.02M
4.69%
-598.27K
-12.95%
Dec 31, 2025
Baron Capital Management, Inc.
2.30M
2.69%
+1.07M
+86.17%
Dec 31, 2025
HealthCor Partners Management LP
6.70M
7.81%
--
--
Dec 31, 2025
Schusterman Interests LLC
1.94M
2.26%
--
--
Dec 31, 2025
Capricorn Investment Group LLC
1.66M
1.94%
-2.26M
-57.64%
Dec 31, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
TrueShares Technology, AI & Deep Learning ETF
3.13%
Global X HealthTech ETF
1.75%
Fidelity Blue Chip Growth ETF
0.07%
T Rowe Price Small-Mid Cap ETF
0.06%
iShares Health Innovation Active ETF
0.02%
Schwab U.S. Small-Cap ETF
0.02%
Fidelity Nasdaq Composite Index ETF
0.01%
Schwab U.S. Broad Market ETF
0%
TrueShares Technology, AI & Deep Learning ETF
占比3.13%
Global X HealthTech ETF
占比1.75%
Fidelity Blue Chip Growth ETF
占比0.07%
T Rowe Price Small-Mid Cap ETF
占比0.06%
iShares Health Innovation Active ETF
占比0.02%
Schwab U.S. Small-Cap ETF
占比0.02%
Fidelity Nasdaq Composite Index ETF
占比0.01%
Schwab U.S. Broad Market ETF
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
KeyAI